Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ERNA”

213 pharma patents match "ERNA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 213
Index total 30,257
Page 3 / 9

Quick answer

This filtered view shows 213 pharmaceutical patents matching "ERNA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

213 results for “ERNA” · 30,257 patents in full index Clear search

  1. AU 2019294474

    Pyridine derivatives substituted by heterocyclic ring and amino group

    BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] · Granted Feb 11, 2021 · Expires Feb 6, 2041

    granted
  2. US 10899826

    Pharmaceutical compositions for an anti-CGRP antagonist antibody

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  3. US 10874635

    Tocotrienol compositions

    First Tech International Limited · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  4. US 10869901

    Hydrolyzed chicken sternal cartilage extract, method for producing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  5. US 10689352

    Solid state forms of trisodium valsartan: sacubitril

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  6. US 10676498

    Processes for the preparation of sofosbuvir and intermediates thereof

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  7. US 10646443

    Sustained release olanzapine formulations

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted May 12, 2020 · Expires May 7, 2040

    granted
  8. US 10604537

    Solid state forms of ixazomib citrate

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  9. US 10604806

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  10. US 10597448

    Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  11. US 10556945

    Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  12. US 10550195

    Tumor selective macropinocytosis-dependent rapidly internalizing antibodies

    The Regents of the University of California · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  13. US 10526656

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  14. US 10519224

    Treating headache comprising administering an antibody to calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  15. US 10508307

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted
  16. US 10479839

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  17. US 10415881

    Method and device for freeze-drying drug liposomes powder assisted by variable-frequency alternating-current electric field

    South China University of Technology · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  18. US 10400045

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  19. US 10392434

    Treating refractory migraine

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  20. US 10329343

    Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  21. US 10323085

    Methods of treating fibromyalgia

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  22. US 10314819

    Solid state forms of Eluxadoline

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  23. US 10308927

    Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease

    The United States of America, as represented by the Secretary of Homeland Security · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  24. US 10285940

    Multicomponent, internally structured nanoemulsions and methods of production

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted